ThinkableWhat is this?

Biotechnology & Genomics

The Man Who Plays Chess With His Mind — And What It Actually Proves

In January 2024, a paralysed man named Noland Arbaugh had a coin-sized chip placed in his skull, and within weeks he was playing online chess and video games using nothing but thought.

The Idea

A brain-computer interface, or BCI, works on a surprisingly legible principle: the motor cortex fires electrical patterns when you intend to move, even when the body cannot follow through. Capture those patterns with enough electrodes, decode them with machine learning, and you can route intention directly into a digital command. No muscles required. The idea has been around since the 1970s, but it has spent most of that time marooned in academic labs, useful in controlled demonstrations and not much else. What shifted is a combination of miniaturisation, robotics, and AI signal processing. Neuralink's N1 implant uses a robotic surgeon to thread 1,024 ultra-fine electrodes into the motor cortex — the equivalent of going from a few microphones in a stadium to an array placed close to individual musicians. The device reads electrical signals generated when a patient thinks about movement, then translates those signals into cursor control on a screen. The critical engineering insight is that the brain is plastic enough to meet the technology halfway: patients learn to modulate their neural signals deliberately, the way you might learn to control a new muscle. That plasticity is both the system's greatest asset and its deepest limitation. When Neuralink's first device had some electrode threads retract from their optimal positions, reducing useful signal, the team adapted the software to extract more from what remained — and performance held. The hardware failed; the brain compensated.

In the World

Noland Arbaugh was paralysed from the shoulders down after a diving accident in 2016. In January 2024 he became the first human to receive Neuralink's N1 implant — a device surgically placed in the skull that reads electrical signals from the motor cortex and translates intended movement into digital commands. Early public demonstrations showed him moving a computer cursor, playing online chess, and playing Civilization VI hands-free; he described how Neuralink had given him the ability to play that game again, which he had previously given up. By August 2025, he was using the device roughly 10 hours a day — for chess, for neuroscience coursework at a community college in Arizona, for scheduling, and for communication — and had described the implant as restoring a sense of autonomy he thought was permanently gone. He became, in effect, the industry's only long-term public case study: the richest window yet into how a BCI performs outside a controlled lab, including its failures. Meanwhile, Synchron, a rival company using a different approach — threading its Stentrode device through a blood vessel rather than requiring open-brain surgery — has been running clinical trials across sites in the United States, Australia, and the United Kingdom. By November 2026, no motor BCI has received full FDA approval. What exists is proof of concept, at scale, in living humans.

Why It Matters

The easy version of this story is about disabled people regaining lost function — and that is genuinely extraordinary. But the deeper implication is structural. BCIs are, at their core, a new input layer between mind and machine. Right now that layer is being built for people with severe paralysis, ALS, and spinal cord injuries, because that is where the medical need is clearest and regulatory paths are most legible. But the same architecture — read intention, route to device — does not stop at the clinic. In May 2025, Apple unveiled a BCI Human Interface Device protocol, formally recognising neural interfaces as a native input category alongside touch, voice, and keyboard, with Synchron becoming the first BCI company to achieve native integration with iPhone, iPad, and Apple Vision Pro. The question the field is quietly circling is not whether BCIs will become more capable, but who gets to define what they are for. Medical restoration is unambiguous. Cognitive enhancement, surveillance of neural data, and employer-mandated use are not. Several jurisdictions already classify brain data as a protected category of sensitive personal information. The technology is moving faster than the ethical frameworks designed to govern it — which is, historically, when the most important decisions get made by the least accountable people.

A Question to Ponder

If a BCI could genuinely make you faster, sharper, or more focused — not to restore something lost, but to exceed what you had — would you want one, and who should get to decide whether you can?

One reader's Thinkable for Tech Tuesday — a random draw from the library.

Start learning with Thinkable
Get your own draw, every day.Start free